canada-istock-471706898-mironovak--3

mironovak / iStockphoto.com

6 June 2018Americas

Pfizer Canada makes investment in developing therapeutic treatments

Pfizer Canada has announced a C$1.2 million (US$931,000) investment for the Neomed Institute in an effort to accelerate transforming scientific discoveries from Canadian universities into innovative therapeutic treatments.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent